FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1817362387> ?p ?o ?g. }

• W1817362387 endingPage "5534" @default.
• W1817362387 startingPage "5529" @default.
• W1817362387 abstract "ABSTRACT Methicillin-resistant Staphylococcus aureus (MRSA) isolates have arisen with reduced susceptibility to several anti-MRSA agents. Telavancin (TLV), a novel anti-MRSA agent, retains low MICs against these organisms. Our objective was to determine the MICs for TLV, daptomycin (DAP), vancomycin (VAN), and linezolid (LZD) against daptomycin-nonsusceptible (DNS) S. aureus , vancomycin-intermediate S. aureus (VISA), heteroresistant VISA (hVISA), and linezolid-resistant (LZD r ) S. aureus . We also evaluated these agents against each phenotype in pharmacokinetic/pharmacodynamic (PK/PD) models. Seventy DNS, 100 VISA, 180 hVISA, and 25 LZD r MRSA isolates were randomly selected from our library and tested to determine their MICs against TLV, DAP, VAN, and LZD via broth microdilution and a Trek panel. Four isolates were randomly selected for 168-h in vitro models to evaluate treatment with TLV at 10 mg/kg of body weight/day, DAP at 10 mg/kg/day, VAN at 1 g every 12 h (q12h), and LZD at 600 mg q12h. The MIC 50/90 for TLV, DAP, VAN, and LZD against 70 DNS S. aureus isolates were 0.06/0.125 μg/ml, 2/4 μg/ml, 1/2 μg/ml, and 2/2 μg/ml, respectively. Against 100 VISA isolates, the MIC 50/90 were 0.06/0.125 μg/ml, 1/1 μg/ml, 4/8 μg/ml, and 1/2 μg/ml, respectively. Against 170 hVISA isolates, the MIC 50/90 were 0.06/0.125 μg/ml, 0.5/1 μg/ml, 1/2 μg/ml, and 1/2 μg/ml, respectively. Against 25 LZD r isolates, the MIC 50/90 were 0.03/0.06 μg/ml, 1/1 μg/ml, 2/2 μg/ml, and 8/8 μg/ml, respectively. The TLV MIC was >0.125 μg/ml for 10/365 (2.7%) isolates. In PK/PD models, TLV was universally bactericidal at 168 h and statistically superior to all antibiotics against DNS S. aureus strain R2334. These data further establish the potency of TLV against resistant MRSA. The model data demonstrate in vitro bactericidal activity of TLV against hVISA, VISA, DNS S. aureus , and LZD r S. aureus strains. Further clinical research is warranted." @default.
• W1817362387 created "2016-06-24" @default.
• W1817362387 creator A5019624240 @default.
• W1817362387 creator A5027690506 @default.
• W1817362387 creator A5060754459 @default.
• W1817362387 creator A5074961750 @default.
• W1817362387 creator A5084829703 @default.
• W1817362387 date "2015-09-01" @default.
• W1817362387 modified "2023-09-23" @default.
• W1817362387 title "Telavancin Demonstrates Activity against Methicillin-Resistant Staphylococcus aureus Isolates with Reduced Susceptibility to Vancomycin, Daptomycin, and Linezolid in Broth Microdilution MIC and One-Compartment Pharmacokinetic/Pharmacodynamic Models" @default.
• W1817362387 cites W1974113734 @default.
• W1817362387 cites W2002617785 @default.
• W1817362387 cites W2034179516 @default.
• W1817362387 cites W2039750453 @default.
• W1817362387 cites W2094922170 @default.
• W1817362387 cites W2114570176 @default.
• W1817362387 cites W2117409056 @default.
• W1817362387 cites W2118726060 @default.
• W1817362387 cites W2119704410 @default.
• W1817362387 cites W2132629057 @default.
• W1817362387 cites W2141948883 @default.
• W1817362387 cites W2147723850 @default.
• W1817362387 cites W2149894508 @default.
• W1817362387 cites W2151547308 @default.
• W1817362387 cites W2163780760 @default.
• W1817362387 cites W2167031235 @default.
• W1817362387 doi "https://doi.org/10.1128/aac.00773-15" @default.
• W1817362387 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4538535" @default.
• W1817362387 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26124162" @default.
• W1817362387 hasPublicationYear "2015" @default.
• W1817362387 type Work @default.
• W1817362387 sameAs 1817362387 @default.
• W1817362387 citedByCount "21" @default.
• W1817362387 countsByYear W18173623872015 @default.
• W1817362387 countsByYear W18173623872016 @default.
• W1817362387 countsByYear W18173623872017 @default.
• W1817362387 countsByYear W18173623872018 @default.
• W1817362387 countsByYear W18173623872019 @default.
• W1817362387 countsByYear W18173623872020 @default.
• W1817362387 countsByYear W18173623872021 @default.
• W1817362387 countsByYear W18173623872022 @default.
• W1817362387 crossrefType "journal-article" @default.
• W1817362387 hasAuthorship W1817362387A5019624240 @default.
• W1817362387 hasAuthorship W1817362387A5027690506 @default.
• W1817362387 hasAuthorship W1817362387A5060754459 @default.
• W1817362387 hasAuthorship W1817362387A5074961750 @default.
• W1817362387 hasAuthorship W1817362387A5084829703 @default.
• W1817362387 hasBestOaLocation W18173623871 @default.
• W1817362387 hasConcept C111113717 @default.
• W1817362387 hasConcept C112705442 @default.
• W1817362387 hasConcept C176947019 @default.
• W1817362387 hasConcept C2777052132 @default.
• W1817362387 hasConcept C2778651397 @default.
• W1817362387 hasConcept C2778980435 @default.
• W1817362387 hasConcept C2779489039 @default.
• W1817362387 hasConcept C2780950330 @default.
• W1817362387 hasConcept C2781414143 @default.
• W1817362387 hasConcept C501593827 @default.
• W1817362387 hasConcept C523546767 @default.
• W1817362387 hasConcept C54355233 @default.
• W1817362387 hasConcept C71924100 @default.
• W1817362387 hasConcept C86803240 @default.
• W1817362387 hasConcept C89423630 @default.
• W1817362387 hasConcept C98274493 @default.
• W1817362387 hasConceptScore W1817362387C111113717 @default.
• W1817362387 hasConceptScore W1817362387C112705442 @default.
• W1817362387 hasConceptScore W1817362387C176947019 @default.
• W1817362387 hasConceptScore W1817362387C2777052132 @default.
• W1817362387 hasConceptScore W1817362387C2778651397 @default.
• W1817362387 hasConceptScore W1817362387C2778980435 @default.
• W1817362387 hasConceptScore W1817362387C2779489039 @default.
• W1817362387 hasConceptScore W1817362387C2780950330 @default.
• W1817362387 hasConceptScore W1817362387C2781414143 @default.
• W1817362387 hasConceptScore W1817362387C501593827 @default.
• W1817362387 hasConceptScore W1817362387C523546767 @default.
• W1817362387 hasConceptScore W1817362387C54355233 @default.
• W1817362387 hasConceptScore W1817362387C71924100 @default.
• W1817362387 hasConceptScore W1817362387C86803240 @default.
• W1817362387 hasConceptScore W1817362387C89423630 @default.
• W1817362387 hasConceptScore W1817362387C98274493 @default.
• W1817362387 hasIssue "9" @default.
• W1817362387 hasLocation W18173623871 @default.
• W1817362387 hasLocation W18173623872 @default.
• W1817362387 hasLocation W18173623873 @default.
• W1817362387 hasLocation W18173623874 @default.
• W1817362387 hasOpenAccess W1817362387 @default.
• W1817362387 hasPrimaryLocation W18173623871 @default.
• W1817362387 hasRelatedWork W1949049279 @default.
• W1817362387 hasRelatedWork W2018382434 @default.
• W1817362387 hasRelatedWork W2077228024 @default.
• W1817362387 hasRelatedWork W2096363361 @default.
• W1817362387 hasRelatedWork W2108737426 @default.
• W1817362387 hasRelatedWork W2133047730 @default.
• W1817362387 hasRelatedWork W2991611600 @default.
• W1817362387 hasRelatedWork W3195958508 @default.
• W1817362387 hasRelatedWork W4200033266 @default.
• W1817362387 hasRelatedWork W4295101986 @default.
• W1817362387 hasVolume "59" @default.

• next